|
Judith A. Fox Ph.D. joined Sunesis in 2006 as Senior Director Program Leader and now serves as Vice President Product and Preclinical Development. Previously she served as Senior Director in the Translational Sciences Department for Chiron Corporation (now Novartis AG) from 2005 to 2006 where she led the clinical pharmacology and preclinical pharmokinetics (PK)/drug metabolism group supporting the development of the company's novel oncology compounds. From 2002 to 2005 Dr. Fox was Senior Director/Senior Staff Scientist for Genencor International where she started the Pharmacological Sciences Department. Dr. Fox's industry career began at Genentech Inc. in the PK/Metabolism Department where she ultimately led the group responsible for oncology projects from late-stage research through clinical development. This was preceded by leadership of the immunology focus area within the PK/Metabolism Department. During her ten years at Genentech she contributed to the development of products such as Herceptin® Xolair® Raptiva® and Avastin®. Dr. Fox received her Ph.D. in Biological Chemistry from the Massachusetts Institute of Technology and an A.B. in Chemistry from Bryn Mawr College. She conducted postdoctoral research at The Rockefeller University. | 